Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04827394 · ClinicalTrials.gov registry record · NA
Neonatal Warming to Prevent Hypothermia
A NA study of Hypothermia, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT04827394: Completed NA study of Hypothermia, sponsored by University of Oklahoma.
NCT04827394 is a NA study of Hypothermia that has completed, run by University of Oklahoma. The registered enrollment target is 52 participants, above the 43-participant average among 9 other Hypothermia trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04827394, a NA study of Hypothermia, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are proposing a pilot randomized controlled trial evaluating the benefit of immediately warming preterm babies using a warming mattress and a plastic wrap, while delaying clamping the umbilical cord at the time of c-section in babies born between 32 and 36 weeks to determine if it reduces the risk of hypothermia.
Primary Outcome
Temperature at arrival to the Warmer
Conditions Studied
Interventions
- DEVICE Neonatal warming mattress
- DEVICE Sterile polyethylene wrap
Study Locations (1)
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-02-21 |
| Phase | NA |
What the finished NCT04827394 record still lists
NCT04827394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, above the 43-participant average among 9 other Hypothermia trials with a reported enrollment target (21% higher).
The record links to 1 condition, with Hypothermia appearing as the primary indexed condition, and to 2 interventions - of which Neonatal warming mattress is the first listed.
NCT04827394 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT04827394 about?
NCT04827394 is a clinical study titled "Neonatal Warming to Prevent Hypothermia". Researchers are proposing a pilot randomized controlled trial evaluating the benefit of immediately warming preterm babies using a warming mattress and a plastic wrap, while delaying clamping the umbilical cord at the time of c-section in babies born between 32 and 36 weeks to determine if it reduce...
What is the current status of trial NCT04827394?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2020-12-01. Estimated completion is 2023-02-21.
What conditions does trial NCT04827394 study?
This clinical trial studies the following conditions: Hypothermia.
What interventions are being tested in trial NCT04827394?
The interventions under investigation include: Neonatal warming mattress (DEVICE), Sterile polyethylene wrap (DEVICE).
Who is sponsoring clinical trial NCT04827394?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04827394 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothermia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04827394's enrollment target sits among peer trials
52 2nd of 9 the highest of 9 other Hypothermia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypothermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Blood Warming in Preterm Infants to Decrease Hypothermia
RECRUITING · NA
-
Thermal Compression Device for Maintenance of Perioperative Normothermia
COMPLETED · NA
-
Hypothermia to Treat Severe Brain Injury
COMPLETED · NA
-
Comparison of Bi-environmental Conditions During Occupational Related Activity
COMPLETED · NA
-
Optimal Positioning of Nasopharyngeal Temperature Probes: A Prospective Cohort Study
COMPLETED · NA
-
Safety and Performance Monitoring During Occupational Work II
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI